These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2235171)

  • 21. Protective efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid-conjugate vaccine.
    Nelson WL; Granoff DM
    Am J Dis Child; 1990 Mar; 144(3):292-5. PubMed ID: 2305734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
    Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
    Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eradication of Haemophilus influenzae type b disease in southern California. Kaiser-UCLA Vaccine Study Group.
    Vadheim CM; Greenberg DP; Eriksen E; Hemenway L; Bendana N; Mascola L; Ward JI
    Arch Pediatr Adolesc Med; 1994 Jan; 148(1):51-6. PubMed ID: 8143010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.
    Lee CY; Thipphawong J; Huang LM; Lee PI; Chiu HH; Lin W; Debois H; Harrison D; Xie F; Barreto L
    Pediatrics; 1999 Jan; 103(1):25-30. PubMed ID: 9917435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months. Haemophilus Influenzae Vaccine Efficacy Study Group.
    Wenger JD; Pierce R; Deaver KA; Plikaytis BD; Facklam RR; Broome CV
    Lancet; 1991 Aug; 338(8764):395-8. PubMed ID: 1678080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population.
    Santosham M; Hill J; Wolff M; Reid R; Lukacs L; Ahonkhai V
    Pediatr Infect Dis J; 1991 Feb; 10(2):113-7. PubMed ID: 2062601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of antigenuria after immunization with three Haemophilus influenzae type b conjugate vaccines.
    Rothstein EP; Madore DV; Girone JA; Schiller RP; Hipp TJ; Souder RL; Bernstein HH
    Pediatr Infect Dis J; 1991 Apr; 10(4):311-4. PubMed ID: 2062627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of Haemophilus influenzae type B vaccines in children with hepatoportoenterostomies.
    Rosenthal P; Wong V; Ross LA; Kim KS
    J Pediatr Gastroenterol Nutr; 1990 Aug; 11(2):201-4. PubMed ID: 2395059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of conjugated PRP vaccines on the incidence of invasive diseases caused by Haemophilus influenzae Type B in childhood].
    Desgrandchamps D; Schmid R; Zimmermann HP; Imahorn P; Kabus K; Schubiger G
    Schweiz Med Wochenschr; 1994 Apr; 124(14):575-82. PubMed ID: 8184297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postlicensure surveillance for Haemophilus influenzae type b invasive disease after use of Haemophilus influenzae type b oligosaccharide CRM197 conjugate vaccine in a large defined United States population: a four-year eight-month follow-up.
    Shinefield HR; Black S
    Pediatr Infect Dis J; 1995 Nov; 14(11):978-81. PubMed ID: 8584366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines.
    Lieberman JM; Greenberg DP; Wong VK; Partridge S; Chang SJ; Chiu CY; Ward JI
    J Pediatr; 1995 Feb; 126(2):198-205. PubMed ID: 7844665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associated or combined vaccination of Brazilian infants with a conjugate Haemophilus influenzae type b (Hib) vaccine, a diphtheria-tetanus-whole-cell pertussis vaccine and IPV or OPV elicits protective levels of antibodies against Hib.
    Araújo OO; Forleo-Neto E; Vespa GN; Puccini RF; Weckx LW; Carvalho ES; Farhat CK
    Vaccine; 2000 Sep; 19(2-3):367-75. PubMed ID: 10930692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
    Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
    Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older. Recommendations of the immunization practices advisory committee (ACIP).
    MMWR Recomm Rep; 1991 Jan; 40(RR-1):1-7. PubMed ID: 1899280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Finnish efficacy trials with Haemophilus influenzae type b vaccines.
    Eskola J; Peltola H; Käyhty H; Takala AK; Mäkelä PH
    J Infect Dis; 1992 Jun; 165 Suppl 1():S137-8. PubMed ID: 1588148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
    Walter EB; Moggio MV; Drucker RP; Wilfert CM
    Pediatr Infect Dis J; 1990 Sep; 9(9):632-5. PubMed ID: 2235187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SAFETY OF A CRM197-CONJUGATED HAEMOPHILUS INFLUENZAE TYPE B VACCINE IN KOREAN CHILDREN.
    Song H; Bock H; Guadagno A; Costantini M; Baehner F; Kim YH; Ahn SI; Son KH; Yim DS
    Southeast Asian J Trop Med Public Health; 2015 Jul; 46(4):743-52. PubMed ID: 26867395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenicity of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age.
    Lepow ML; Samuelson JS; Gordon LK
    J Pediatr; 1985 Feb; 106(2):185-9. PubMed ID: 3871477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections.
    Lagos R; Horwitz I; Toro J; San Martin O; Abrego P; Bustamante C; Wasserman SS; Levine OS; Levine MM
    Pediatr Infect Dis J; 1996 Mar; 15(3):216-22. PubMed ID: 8852909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.